Table 1.
Demographic characteristics of the study participants infected with RVA in Kilifi.
| Characteristics | RVA positives (per cent) | Successfully sequenced G2P[4] (per cent) | All G2P[4] (per cent) | Non-G2P[4] (per cent) | All G2P[4] vs. non-G2P[4] P-value |
|---|---|---|---|---|---|
| Total cases | 429 | 63 (14.7) | 87 (20.3) | 342 (79.7) | |
| Vaccine period | 0.039 | ||||
| Pre-vaccine | 215 (49.9) | 32 (50.7) | 35 (40.2) | 180 (52.6) | |
| Post-vaccine | 214 (50.1) | 31 (49.3) | 52 (59.8) | 162 (47.4) | |
| Age (in months) | 0.944 | ||||
| Mean (SD) | 14.9 (13.1) | 17.6 (16.4) | 16.9 (15.4) | 14.4 (12.4) | |
| Median (IQR) | 11.7 (8.3–17.9) | 11.2 (8.6–20.7) | 10.6 (8.4–19.7) | 12.2 (8.3–16.8) | |
| Age group (in months) | 0.092 | ||||
| 0–11 | 216 (50.4) | 33 (52.4) | 47 (54.0) | 216 (50.4) | |
| 12–23 | 169 (39.4) | 20 (31.2) | 26 (29.9) | 143 (41.8) | |
| 24–59 | 35 (8.2) | 7 (11.1) | 11 (12.6) | 24 (7.0) | |
| ≥60 | 9 (2.1) | 3 (4.8) | 3 (3.5) | 6 (1.7) | |
| Gender | 0.789 | ||||
| Male | 251 (51.5) | 37 (58.7) | 52 (59.7) | 199 (58.2) | |
| Vaccination status | 0.129 | ||||
| Vaccinated | 88 (20.6) | 14 (22.2) | 22 (25.6) | 66 (19.4) | |
| Not vaccinated | 215 (50.4) | 33 (52.4) | 35 (40.7) | 180 (52.8) | |
| Unknown | 124 (29.0) | 16 (25.4) | 29 (33.7) | 95 (27.9) | |
| Full vaccinationa | 79 (18.4) | 13 (20.6) | 21 (24.1) | 58 (17.0) | 0.256 |
a
Full vaccination implies that the participants received two doses of the Rotarix vaccine as recommended by the WHO.